The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
The PedsQL™ in pediatric patients with Spinal Muscular Atrophy: Feasibility, reliability, and validity of the Pediatric Quality of Life Inventory™ Generic Core Scales and Neuromuscular Module
Open accessAbstract
For Phase II and III clinical trials in children with Spinal Muscular Atrophy (SMA), reliable and valid outcome measures are necessary. Since 2000, the American Spinal Muscular Atrophy Randomized Trials (AmSMART) group has established reliability and validity for measures of strength, lung function, and motor function in the population from age 2 years to 18 years. The PedsQL™ (Pediatric Quality of Life Inventory™) Measurement Model was designed to integrate the relative merits of generic and disease-specific approaches, with disease-specific modules. The PedsQL™ 3.0 Neuromuscular Module was designed to measure HRQOL dimensions specific to children ages 2 to 18 years with neuromuscular disorders, including SMA. One hundred seventy-six children with SMA and their parents completed the PedsQL™ 4.0 Generic Core Scales and PedsQL™ 3.0 Neuromuscular Module. The PedsQL™ demonstrated feasibility, reliability and validity in the SMA population. Consistent with the conceptualization of disease-specific symptoms as causal indicators of generic HRQOL, the majority of intercorrelations among the Neuromuscular Module Scales and the Generic Core Scales were in the medium to large range, supporting construct validity. For the purposes of a clinical trial, the PedsQL™ Neuromuscular Module and Generic Core Scales provide an integrated measurement model with the advantages of both generic and condition-specific instruments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Forming inferences about some intraclass correlation coefficients.
McGraw, K. O., & Wong, S. P. (1996) · Psychological Methods · doi:10.1037/1082-989x.1.1.30 · Cited by 6,903
Achenbach, T. M., McConaughy, S. H., & Howell, C. T. (1987) · Psychological Bulletin · doi:10.1037/0033-2909.101.2.213 · Cited by 5,436
Varni, J. W., Seid, M., & Kurtin, P. S. (2001) · Medical Care · doi:10.1097/00005650-200108000-00006 · Cited by 5,131 · cited 3×
“0 initial field test[25] and a State’s Children’s Health Insurance Program(SCHIP) evaluation in California[28].”
BackgroundSelf-citationMcHorney, C. A., Ware, J. E., Rachel Lu, J. F., & Sherbourne, C. D. (1994) · Medical Care · doi:10.1097/00005650-199401000-00004 · Cited by 4,458
The PedsQL™: Measurement Model for the Pediatric Quality of Life Inventory
Varni, J. W., Seid, M., & Rode, C. A. (1999) · Medical Care · doi:10.1097/00005650-199902000-00003 · Cited by 3,291
Self-citationVarni, J. W., Seid, M., Smith Knight, T., Burwinkle, T., Brown, J., & Szer, I. S. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10095 · Cited by 535
Self-citationPsychometric considerations in evaluating health-related quality of life measures
Hays, R. D., Anderson, R., & Revicki, D. (1993) · Quality of Life Research · doi:10.1007/bf00422218 · Cited by 513
Cited by
Results from a phase 1 study of nusinersen (ISIS-SMN Rx ) in children with spinal muscular atrophy
Chiriboga, C. A., Swoboda, K. J., Darras, B. T., Iannaccone, S. T., Montes, J., De Vivo, D. C., Norris, D. A., Bennett, C. F., & Bishop, K. M. (2016) · Neurology · doi:10.1212/wnl.0000000000002445 · Cited by 612
Self-citationMercuri, E., Sumner, C. J., Muntoni, F., Darras, B. T., & Finkel, R. S. (2022) · Nature Reviews Disease Primers · doi:10.1038/s41572-022-00380-8 · Cited by 430
Childhood spinal muscular atrophy: controversies and challenges
Mercuri, E., Bertini, E., & Iannaccone, S. T. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70061-3 · Cited by 423
Self-citationProspective cohort study of spinal muscular atrophy types 2 and 3
Kaufmann, P., McDermott, M. P., Darras, B. T., Finkel, R. S., Sproule, D. M., Kang, P. B., Oskoui, M., Constantinescu, A., Gooch, C. L., Foley, A. R., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e318271f7e4 · Cited by 283
Health outcomes in spinal muscular atrophy type 1 following AVXS-101 gene replacement therapy
Al‐Zaidy, S., Pickard, A. S., Kotha, K., Alfano, L. N., Lowes, L., Paul, G., Church, K., Lehman, K., Sproule, D. M., Dabbous, O., et al. (2019) · Pediatric Pulmonology · doi:10.1002/ppul.24203 · Cited by 216
“The devastating nature of this disease significantly reduces healthrelated quality of life (HRQoL) for SMA patients compared to healthy children.(13,14) Compared to patients with SMA type 3 (SMA3), which is a less severe form of SMAwith onset at >18 months and achievement of independent walking,(5) SMA1 patients had l…”
Result
Metadata
- Authors
- Iannaccone, S. T., Hynan, L. S., Morton, A., Buchanan, R., Limbers, C. A., & Varni, J. W.
- Venue
- Neuromuscular Disorders
- Publisher
- Elsevier BV
- Published
- 2009-12
- Volume
- 19
- Issue
- 12
- Pages
- 805-812
- ISSN
- 0960-8966 (ISSN-L)
- OpenAlex
- W2023028623
- Cited by
- 164
- References
- 7
- FWCI
- 2.46
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The PedsQL™ in pediatric patients with Spinal Muscular Atrophy: Feasibility, reliability, and validity of the Pediatric Quality of Life Inventory™ Generic Core Scales and Neuromuscular Module. https://app.cochat.ai/papers/10.1016/j.nmd.2009.09.009
- The paper
- Iannaccone, S. T., Hynan, L. S., Morton, A., Buchanan, R., Limbers, C. A., & Varni, J. W. (2009). The PedsQL™ in pediatric patients with Spinal Muscular Atrophy: Feasibility, reliability, and validity of the Pediatric Quality of Life Inventory™ Generic Core Scales and Neuromuscular Module. Neuromuscular Disorders. https://doi.org/10.1016/j.nmd.2009.09.009
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.